Results 111 to 120 of about 59,365 (240)

Long-term clinical safety and efficacy of drug-eluting stents in real-world patients [PDF]

, 2011
Since the fi rst balloon angioplasty was performed in the late 1970’s, percutaneous coronary intervention (PCI) has undergone rapid transformation to become an essential treatment option for coronary artery disease as an alternative to surgery.
Kukreja, N. (Neville)
core   +1 more source

Negative Pressure Wound Therapy as a Key Strategy in the Management of Severe Diabetic Foot Ulcers in Septic Frail Patients: A Case Series

International Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Diabetes mellitus represents a major global health challenge, with over 537 million adults currently affected worldwide. Among its complications, diabetic foot ulcers remain a leading cause of morbidity, hospitalization and amputation, imposing a significant socioeconomic burden.
Maria Ignacy Pirski, Silvia Malerba, Luigi Marano, Martyna Kur, Jaroslaw Skokowski, Maciej Świerblewski   +5 more
wiley   +1 more source

Nanoparticle coatings for controlled release of quercetin from an angioplasty balloon. [PDF]

PLoS One, 2022
Craciun I, Astete CE, Boldor D, Jennings MH, Gorman JD, Sabliov CM, Dugas TR.   +6 more
europepmc   +1 more source

Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis - Tissue characteristics compared to primary atherosclerosis [PDF]

, 2004
Pathogenic events leading to in-stent restenosis (ISR) are still incompletely understood. Among others, inflammation, immune reactions, deregulated cell death and growth have been suggested. Therefore, atherectomy probes from 21 patients with symptomatic
Abdelmegui AE, Alexander Jabs, Bauriedel G, Bauriedel G, Berndt Lüderitz, Carter AJ, Chiu B, Dirk Skowasch, Epstein SE, Farb A, Gerhard Bauriedel, Kearney M, Kol A, Komatsu R, Mayr M, Moreno PR, Neumann FJ, Nicolas Wernert, O'Brien ER, Pickering JG, René Andrié, Sabine Dinkelbach, Simonton CA, Thomas M. Schiele, Zohlnhofer D   +24 more
core   +1 more source

AP‐1‐Targeting Decoy Oligonucleotides: Mechanisms and Therapeutic Potential as Modulators of Inflammatory Pathways

Journal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Numerous cellular functions, such as apoptosis, proliferation, differentiation, survival, transformation and cell migration, are regulated by a crucial transcription factor called activator protein 1 (AP‐1). Growing evidence indicates that AP‐1 is involved in severe conditions like fibrosis, cancer, and organ damage, as well as inflammatory ...
Maryam Mahjoubin‐Tehran, Samaneh Rezaei, Vasily N. Sukhorukov, Amin Jalili, Prashant Kesharwani, Amirhossein Sahebkar   +5 more
wiley   +1 more source

Efficacy of Short Balloon Inflation Time in Infrapopliteal Angioplasty for Chronic Limb-threatening Ischemia: Short-term Outcomes from a Single Center

Indian Journal of Vascular and Endovascular Surgery
Objectives: Peripheral arterial disease, particularly infrapopliteal disease, is closely associated with diabetes. While infrapopliteal angioplasty has gained global acceptance, there is no consensus on optimal balloon inflation time.
Manoj Shankarrao Hambarde, Deepika Chandran, Rakshith Mohan, Roma Paul, Sunil Rajendran   +4 more
doaj   +1 more source

Adjunctive strategies in the management of resistant, 'undilatable' coronary lesions after successfully crossing a CTO with a guidewire. [PDF]

, 2014
Successful revascularisation of chronic total occlusions (CTOs) remains one of the greatest challenges in the era of contemporary percutaneous coronary intervention (PCI).
Fairley, SL, Hanratty, C, Rana, O, Spratt, JC, Talwar, S, Walsh, S   +5 more
core   +1 more source

Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry

Diagnostic and Interventional Radiology, 2018
PURPOSE:Debulking strategies prior to drug-coated balloon (DCB) angioplasty were suggested to improve clinical results in femoro-popliteal lesions. Currently, there are no data regarding plaque modification with a scoring balloon with subsequent DCB ...
Magnus Baumhäkel, Shalva Chkhetia, Michael Kindermann   +2 more
doaj   +1 more source

Perfil dos pacientes submetidos à angioplastia trasluminal coronariana com stents farmacológicos no Instituto de Cardiologia de Santa Catarina. [PDF]

, 2007
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Aquino, Vivian Wuerges de
core  

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Balloon angioplasty with drug‐coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in‐stent restenosis. Despite its frequent use, there is a lack of long‐term data on the efficacy of DCB angioplasty.
Sacharias von Koch, Mikael Zhou, Hans Christian Rosén, Sammy Zwackman, Juliane Jurga, Per Grimfjärd, Matthias Götberg, Moman A. Mohammad, David Erlinge   +8 more
doaj   +1 more source